Interactions between vitamin B2, the MTRR rs1801394 and MTR rs1805087 genetic polymorphisms, and colorectal cancer risk in a Korean population
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: We explored whether the association between vitamin B2 and colorectal cancer (CRC) risk could be modified by the MTRR rs1801394 and MTR rs1805087 genetic polymorphisms and examined whether the interaction effects are sex-specific.METHODS: We performed a case-control study involving 1,420 CRC patients and 2,840 controls from the Korea National Cancer Center. Dietary vitamin B2 intake was assessed using a semiquantitative food frequency questionnaire, and the association with CRC was evaluated. Genotyping was performed using an Illumina MEGA-Expanded Array. For gene-nutrient interaction analysis, pre-matched (1,081 patients and 2,025 controls) and matched (1,081 patients and 1,081 controls) subsets were included. Unconditional and conditional logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs).RESULTS: A higher intake of vitamin B2 was associated with a significantly lower CRC risk (OR, 0.65; 95% CI, 0.51 to 0.82; p<0.001). Carriers of at least 1 minor allele of MTRR rs1801394 showed a significantly higher CRC risk (OR, 1.43; 95% CI, 1.12 to 1.83). Males homozygous for the major allele (A) of MTRR rs1801394 and who had a higher intake of vitamin B2 had a significantly lower CRC risk (OR, 0.31; 95% CI, 0.18 to 0.54; p-interaction=0.02). In MTR rs1805087, males homozygous for the major allele (A) and who had a higher vitamin B2 intake had a significantly lower CRC risk (OR, 0.38; 95% CI, 0.25 to 0.60; p-interaction<0.001).CONCLUSIONS: The MTRR rs1801394 and MTR rs1805087 genetic polymorphisms may modify the association between vitamin B2 and CRC risk, particularly in males. However, further studies are warranted to confirm these interaction results.
Abstract
OBJECTIVES: We explored whether the association between vitamin B2 and colorectal cancer (CRC) risk could be modified by the MTRR rs1801394 and MTR rs1805087 genetic polymorphisms and examined whether the interaction effects are sex-specific.METHODS: We performed a case-control study involving 1,420 CRC patients and 2,840 controls from the Korea National Cancer Center. Dietary vitamin B2 intake was assessed using a semiquantitative food frequency questionnaire, and the association with CRC was evaluated. Genotyping was performed using an Illumina MEGA-Expanded Array. For gene-nutrient interaction analysis, pre-matched (1,081 patients and 2,025 controls) and matched (1,081 patients and 1,081 controls) subsets were included. Unconditional and conditional logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs).RESULTS: A higher intake of vitamin B2 was associated with a significantly lower CRC risk (OR, 0.65; 95% CI, 0.51 to 0.82; p<0.001). Carriers of at least 1 minor allele of MTRR rs1801394 showed a significantly higher CRC risk (OR, 1.43; 95% CI, 1.12 to 1.83). Males homozygous for the major allele (A) of MTRR rs1801394 and who had a higher intake of vitamin B2 had a significantly lower CRC risk (OR, 0.31; 95% CI, 0.18 to 0.54; p-interaction=0.02). In MTR rs1805087, males homozygous for the major allele (A) and who had a higher vitamin B2 intake had a significantly lower CRC risk (OR, 0.38; 95% CI, 0.25 to 0.60; p-interaction<0.001).CONCLUSIONS: The MTRR rs1801394 and MTR rs1805087 genetic polymorphisms may modify the association between vitamin B2 and CRC risk, particularly in males. However, further studies are warranted to confirm these interaction results.
참고문헌 (50)
- Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71, pp.209~249 (2021)[DOI]
- Kang MJ, "Cancer statistics in Korea : incidence, mortality, survival, and prevalence in 2019", Cancer Res Treat, 54, pp.330~344 (2022)[DOI]
- Sninsky JA, "Risk factors for colorectal polyps and cancer", Gastrointest Endosc Clin N Am, 32, pp.195~213 (2022)[DOI]
- "Diet, nutrition, physical activity, and cancer: a global perspective. A summary of the third expert report" (2018)[URL]
- Arigony AL, "The influence of micronutrients in cell culture : a reflection on viability and genomic stability", Biomed Res Int, 2013, pp.597282~ (2013)[DOI]
- de Vogel S, "Dietary folate, methionine, riboflavin, and vitamin B-6 and risk of sporadic colorectal cancer", J Nutr, 138, pp.2372~2378 (2008)[DOI]
- McNulty H, "Intake and status of folate and related B-vitamins : considerations and challenges in achieving optimal status", Br J Nutr, 99(Suppl 3), pp.S48~S54 (2008)[DOI]
- Jacques PF, "The relationship between riboflavin and plasma total homocysteine in the Framingham Offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene", J Nutr, 132, pp.283~288 (2002)[DOI]
- Wu LL, "Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker", Clin Chim Acta, 322, pp.21~28 (2002)[DOI]
- Sun CF, "Serum total homocysteine increases with the rapid proliferation rate of tumor cells and decline upon cell death : a potential new tumor marker", Clin Chim Acta, 321, pp.55~62 (2002)[DOI]
- Keshteli AH, "Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases : a review", World J Gastroenterol, 21, pp.1081~1090 (2015)[DOI]
- Battistelli S, "Total plasma homocysteine and methylenetetrahydrofolate reductase C677T polymorphism in patients with colorectal carcinoma", World J Gastroenterol, 12, pp.6128~6132 (2006)[DOI]
- Lim YJ, "Hyperhomocysteinemia is a risk factor for colorectal adenoma in women", J Clin Biochem Nutr, 51, pp.132~135 (2012)[DOI]
- Zschäbitz S, "B vitamin intakes and incidence of colorectal cancer : results from the Women’s Health Initiative Observational Study cohort", Am J Clin Nutr, 97, pp.332~343 (2013)[DOI]
- Sun Z, "Reported intake of selected micronutrients and risk of colorectal cancer : results from a large population-based case-control study in Newfoundland, Labrador and Ontario, Canada", Anticancer Res, 32, pp.687~696 (2012)
- Le Marchand L, "B-vitamin intake, metabolic genes, and colorectal cancer risk(United States)", Cancer Causes Control, 13, pp.239~248 (2002)[DOI]
- Kabat GC, "Dietary intake of selected B vitamins in relation to risk of major cancers in women", Br J Cancer, 99, pp.816~821 (2008)[DOI]
- Wu MH, "Contribution of 5-methyltetrahydrofolate-homocysteine methyltransferase reductase genotypes to colorectal cancer in Taiwan", Anticancer Res, 42, pp.2375~2382 (2022)[DOI]
- Jokić M, "Association of MTHFR, MTR, MTRR, RFC1, and DHFR gene polymorphisms with susceptibility to sporadic colon cancer", DNA Cell Biol, 30, pp.771~776 (2011)[DOI]
- Pardini B, "MTHFR and MTRR genotype and haplotype analysis and colorectal cancer susceptibility in a case-control study from the Czech Republic", Mutat Res, 721, pp.74~80 (2011)[DOI]
- Wettergren Y, "MTHFR, MTR, and MTRR polymorphisms in relation to p16INK4A hypermethylation in mucosa of patients with colorectal cancer", Mol Med, 16, pp.425~432 (2010)[DOI]
- de Vogel S, "Genetic variants of methyl metabolizing enzymes and epigenetic regulators : associations with promoter CpG island hypermethylation in colorectal cancer", Cancer Epidemiol Biomarkers Prev, 18, pp.3086~3096 (2009)[DOI]
- Ho D, "MatchIt : nonparametric preprocessing for parametric causal inference", J Stat Softw, 42, pp.1~28 (2011)[DOI]
- Ahn Y, "Validation and reproducibility of food frequency questionnaire for Korean genome epidemiologic study", Eur J Clin Nutr, 61, pp.1435~1441 (2007)[DOI]
- Eussen SJ, "Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer risk", Cancer Epidemiol Biomarkers Prev, 19, pp.2549~2561 (2010)[DOI]
- Yoon YS, "Vitamin B2 intake and colorectal cancer risk; results from the Nurses’ Health Study and the Health Professionals Follow-Up Study cohort", Int J Cancer, 139, pp.996~1008 (2016)[DOI]
- Huang CY, "Dietary B vitamin and methionine intakes and risk for colorectal cancer : a case-control study in China", Br J Nutr, 123, pp.1277~1289 (2020)[DOI]
- Kim J, "Dietary methyl donor nutrients, DNA mismatch repair polymorphisms, and risk of colorectal cancer based on microsatellite instability status", Eur J Nutr, 61, pp.3051~3066 (2022)[DOI]
- Sharp L, "Polymorphisms in the methylenetetrahydrofolate reductase(MTHFR)gene, intakes of folate and related B vitamins and colorectal cancer : a case-control study in a population with relatively low folate intake", Br J Nutr, 99, pp.379~389 (2008)[DOI]
- Rivlin RS, "Riboflavin metabolism", N Engl J Med, 283, pp.463~472 (1970)[DOI]
- Moat SJ, "Effect of riboflavin status on the homocysteine-lowering effect of folate in relation to the MTHFR(C677T)genotype", Clin Chem, 49, pp.295~302 (2003)[DOI]
- Powers HJ, "Riboflavin(vitamin B-2)and health", Am J Clin Nutr, 77, pp.1352~1360 (2003)[DOI]
- Webster RP, "Modulation of carcinogen-induced DNA damage and repair enzyme activity by dietary riboflavin", Cancer Lett, 98, pp.129~135 (1996)[DOI]
- Preiser JC, "Oxidative stress", JPEN J Parenter Enteral Nutr, 36, pp.147~154 (2012)[DOI]
- Ashoori M, "Riboflavin(vitamin B₂)and oxidative stress : a review", Br J Nutr, 111, pp.1985~1991 (2014)[DOI]
- Werner R, "HepG2 cells develop signs of riboflavin deficiency within 4 days of culture in riboflavin-deficient medium", J Nutr Biochem, 16, pp.617~624 (2005)[DOI]
- Wu G, "Glutathione metabolism and its implications for health", J Nutr, 134, pp.489~492 (2004)[DOI]
- Pabalan N, "Associations of the A66G methionine synthase reductase polymorphism in colorectal cancer : a systematic review and meta-analysis", Biomark Cancer, 7(Suppl 1), pp.21~28 (2015)[DOI]
- Han D, "Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility : evidence from 35 case-control studies", Mol Biol Rep, 39, pp.805~816 (2012)[DOI]
- Zhou D, "The polymorphisms in methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase, and the risk of colorectal cancer", Int J Biol Sci, 8, pp.819~830 (2012)[DOI]
- Otani T, "Folate, vitamin B6, vitamin B12, and vitamin B2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in Japan", Nutr Cancer, 53, pp.42~50 (2005)[DOI]
- Wu PP, "A meta-analysis of MTRR A66G polymorphism and colorectal cancer susceptibility", J BUON, 20, pp.918~922 (2015)
- Yu K, "Methionine synthase A2756G polymorphism and cancer risk : a meta-analysis", Eur J Hum Genet, 18, pp.370~378 (2010)[DOI]
- Chen J, "A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer", Cancer Res, 56, pp.4862~4864 (1996)
- Ding W, "Methionine synthase A2756G polymorphism and risk of colorectal adenoma and cancer : evidence based on 27 studies", PLoS One, 8, pp.e60508~ (2013)[DOI]
- Banerjee RV, "Cobalamin-dependent methionine synthase", FASEB J, 4, pp.1450~1459 (1990)[DOI]
- Dekou V, "Gene-environment and gene-gene interaction in the determination of plasma homocysteine levels in healthy middle-aged men", Thromb Haemost, 85, pp.67~74 (2001)[DOI]
- Chen J, "Influence of a methionine synthase(D919G)polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction", Atherosclerosis, 154, pp.667~672 (2001)[DOI]
- de Vogel S, "Dietary methyl donors, methyl metabolizing enzymes, and epigenetic regulators : diet-gene interactions and promoter CpG island hypermethylation in colorectal cancer", Cancer Causes Control, 22, pp.1~12 (2011)[DOI]
- Sharp L, "Polymorphisms in genes involved in folate metabolism and colorectal neoplasia : a HuGE review", Am J Epidemiol, 159, pp.423~443 (2004)[DOI]